SEC Form 4 · accession 0001209191-18-044391
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S. Cuffe
Officer — President-Physician Services
Period of report
Jul 26, 2018
Accepted (ET)
Jul 30, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 26, 2018 | M | 12,500 | $37.18 | A | 33,936 | D | |
| Common StockF1 | Jul 26, 2018 | F | 7,187 | $124.30 | D | 26,749 | D | |
| Common StockF1 | Jul 26, 2018 | G | 589 | $0.00 | D | 26,160 | D | |
| Common StockF2,F1 | Jul 30, 2018 | S | 5,313 | $125.2564 | D | 20,847 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF3 | $37.18 | Jul 26, 2018 | M | 12,500 | D | — | Feb 6, 2023 | Common Stock | 12,500 | 0 | D |
Explanation of responses
- F1Includes 1540.2979 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.24 to $125.30, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.